The medical team at Al-Mouwasat Hospital in Al-Khobar successfully saved the life of a patient suffering from severe abdominal pain and bleeding. Upon the patient’s arrival, having been transferred from another hospital, the emergency department’s medical team conducted a clinical…
Celltrion Reveals Positive Phase III Data for CT-P47 Biosimilar at EULAR 2024 Celltrion presented encouraging Phase III data for CT-P47, a biosimilar candidate referencing RoActemra® in patients with moderate to severe rheumatoid arthritis (RA) at the Annual European Congress of…
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a leading oncology firm, and NewBridge Pharmaceuticals have mutually decided to conclude their partnership in the MENA region. This strategic move is aligned with BeiGene’s aim to directly manage its operations in the…
At the European Hematology Association (EHA) 2024 Hybrid Congress, the data from InnoCare’s (HKEX: 09969; SSE: 688428) robust pipelines were presented, showcasing significant advancements in various areas of hematology research and treatment. About InnoCare:InnoCare (HKEX: 09969; SSE: 688428) is a…
A recent survey conducted by Miracle-Ear, an Amplifon company, delved into the impact of hearing loss on the Gen X and Baby Boomer populations, aged 44 to 78. With data from 1,000 U.S. adults, the survey highlights significant findings regarding…
A recent study of Phoenix’s bioscience ecosystem has pinpointed three areas poised for significant growth and global impact, centered around the Phoenix Bioscience Core and surrounding regional hubs of research and innovation. The report, titled “Leveraging the Phoenix Region’s Bioscience…
Ideal Living, known for its AmazingAir and AquaTru products, will be showcasing at the Health Optimisation Summit in London’s Business Design Centre from June 15-16. This global event gathers experts in biohacking, nutrition, fitness, and preventative medicine to share insights.…
RedSail Technologies, a top provider of pharmacy solutions, has received a strategic growth investment from Leonard Green & Partners (LGP). Additionally, Francisco Partners (FP), the company’s creator through the merging of two divisions in 2020, will reinvest alongside management. This…
AVAVA, Inc., a pioneering medical aesthetics platform company developing safe and effective image-guided intradermal laser products for all skin tones, has secured $35 million in new financing. AVAVA, Inc. has successfully concluded its Series C funding round, securing $25 million…
“Pfizer’s Phase 3 Study on Duchenne Muscular Dystrophy Gene Therapy Falls Short of Primary Endpoint” Pfizer Inc. (NYSE: PFE) has reported that its CIFFREO Phase 3 trial, which evaluated the investigational mini-dystrophin gene therapy, fordadistrogene movaparvovec, in ambulatory Duchenne muscular…
Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Augtyro™ (repotrectinib) for treating adult and pediatric patients aged 12 and above with solid tumors harboring a neurotrophic tyrosine receptor kinase…
Agenus has announced groundbreaking results from a clinical trial, published in Nature Medicine, showcasing the potential of a novel immunotherapy combination for treating microsatellite stable metastatic colorectal cancer (MSS mCRC), a type of cancer typically resistant to immunotherapy. This research,…